Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Healthstream (HSTM) EBIAT (2016 - 2025)

Healthstream (HSTM) has disclosed EBIAT for 16 consecutive years, with $2.5 million as the latest value for Q4 2025.

  • On a quarterly basis, EBIAT fell 48.15% to $2.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $18.3 million, a 8.32% decrease, with the full-year FY2025 number at $18.3 million, down 8.32% from a year prior.
  • EBIAT was $2.5 million for Q4 2025 at Healthstream, down from $6.1 million in the prior quarter.
  • In the past five years, EBIAT ranged from a high of $6.1 million in Q3 2025 to a low of -$387000.0 in Q4 2021.
  • A 5-year average of $3.8 million and a median of $4.1 million in 2022 define the central range for EBIAT.
  • Peak YoY movement for EBIAT: crashed 141.93% in 2021, then soared 1132.56% in 2022.
  • Healthstream's EBIAT stood at -$387000.0 in 2021, then skyrocketed by 1132.56% to $4.0 million in 2022, then surged by 35.56% to $5.4 million in 2023, then dropped by 9.75% to $4.9 million in 2024, then crashed by 48.15% to $2.5 million in 2025.
  • Per Business Quant, the three most recent readings for HSTM's EBIAT are $2.5 million (Q4 2025), $6.1 million (Q3 2025), and $5.4 million (Q2 2025).